Health8/22/2025•The Guardian
Wes Streeting’s row with pharma firms grows as they reject NHS drug pricing offer
The article discusses an ongoing dispute between the UK's Health Secretary, Wes Streeting, and pharmaceutical companies over NHS drug pricing. Drugmakers have rejected Streeting's latest offer, leading to the continuation of an "unsustainable" rebate scheme where the NHS claws back some of the money paid for medicines. The industry argues this scheme could ultimately disadvantage patients, but no agreement was reached by the given deadline. The article suggests the row between Streeting and the pharmaceutical firms has intensified as a result of the failed negotiations.
Note: This is an AI-generated summary of the original article. For the full story, please visit the source link below.
